Telotristat ethyl Not Yet Recruiting Phase 2 Trials for Metastatic Nonfunctional Well Differentiated Neuroendocrine Neoplasm / Carcinoid Syndrome Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03453489AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With Metastatic Well Differentiated Neuroendocrine Neoplasm